Drug & supplement interaction

Antineoplastons + Relugolix

Relugolix brand name: Orgovyx.

No Known Interaction
Medically reviewed by · Updated July 2026 · Pair last verified Sep 20, 2026
The bottom line No known interaction

We found no known interaction between Antineoplastons and Relugolix in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first. Additionally, although there is no interaction, the two are separately associated with some of the same side effects, which would make a new symptom harder to attribute to one or the other.

Know someone taking this? Share
Facebook Post Reddit Email
On this page
Interaction report

Antineoplastons and Relugolix

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Relugolix and Antineoplastons in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

Worth understanding: our licensed dataset holds no drug-interaction record for Antineoplastons at all — not against Relugolix, and not against any other medication we track. This verdict therefore rests on the absence of any recorded data, not on research that looked at this combination and found nothing. We cannot rule an interaction out.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Antineoplastons safety at a glance

Antineoplastons overall Use caution Not FDA-approved; effectiveness is unproven and side effects can be serious, especially at high doses.
Pregnancy Avoid There is no reliable safety data, so use during pregnancy should be avoided.
Breastfeeding Avoid Safety while breastfeeding is unknown, so it should be avoided.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Relugolix and Antineoplastons? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
What to actually watch for

No Interaction Found — But Data Suggests Antineoplastons and Relugolix May Share Several of the Same Side Effects

This is not an interaction. Neither one changes how your body handles the other, and nothing here says they react together. What our sources do show is that each has separately been linked to the effects below — so taking both can make those effects more likely to turn up, and harder to pin on one or the other if they do. 2 of them are worth acting on rather than waiting out — marked below.

  • An irregular heartbeat / Chest pain Worth acting on Additional detail

    Antineoplastons

    “Intravenously, antineoplaston A5 has been associated with palpitations at doses up to 153 mg/kg daily. A 71 year-old male bladder cancer patient experienced chest pressure and irregular heartbeat after receiving intravenous antineoplaston A5 58 mg/kg/day for 5 days. Use of intravenous antineoplaston AS2-1, up to 160 mg/kg daily for over 2 years, has been associated with mild hypertension.”

    Antineoplastons · Natural Medicines adverse-effect record, reported in bladder cancer.

    5 sources cited
    1. 25608. Burzynski SR, Kubove E, Burzynski B. Phase I clinical studies of antineoplaston A5 injections. Drugs Exp Clin Res 1987;13 Suppl 1:37-43.
    2. 25622. Burzynski SR, Kubove E, Burzynski B. Phase I clinical studies of antineoplaston A5 injections. Drugs Exp Clin Res 1987;13 Suppl 1:37-43.
    3. 25604. Tsuda H, Hara H, Eriguchi N, et al. Toxicological study on antineoplastons A-10 and AS2-1 in cancer patients. Kurume Med J 1995;42(4):241-249. PubMed
    4. 25619. Burzynski SR, Burzynski B, Mohabbat MO. Toxicology studies on antineoplaston AS2-1 injections in cancer patients. Drugs Exp Clin Res 1986;12 Suppl 1:25-35.
    5. 25607. Burzynski SR, Kubove E. Phase I clinical studies of antineoplaston A3 injections. Drugs Exp Clin Res 1987;13 Suppl 1:17-29.

    Relugolix

    Listed in the ADVERSE REACTIONS section of the FDA label for Relugolix. Read the label on DailyMed ›

  • Tiredness reported in 31.1% of FDA reports for Relugolix Additional detail

    Antineoplastons

    “Orally and intravenously, headache, fatigue, sleepiness, ringing in the ears, and numbness have been reported for patients treated with antineoplastons A10 and AS2-1. Dizziness has also been noted for some patients treated with oral antineoplaston A10 or intravenous antineoplaston A3.”

    Antineoplastons · Natural Medicines adverse-effect record, reported in cluster headache.

    6 sources cited
    1. 25593. Buckner JC, Malkin MG, Reed E, et al. Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma. Mayo Clin Proc 1999;74(2):137-145. PubMed
    2. 25601. Burzynski SR, Conde AB, Peters A, et al. A retrospective study of antineoplastons A10 and AS2-1 in primary brain tumors. Clin Drug Invest 1999;18(1):1-10.
    3. 25603. Burzynski SR, Lewy RI, Weaver RA, et al. Phase II study of antineoplaston A10 and AS2-1 in patients with recurrent diffuse intrinsic brain stem glioma: a preliminary report. Drugs R D 2003;4(2):91-101. PubMed
    4. 25610. Burzynski SR, Weaver RA, Lewy RI, et al. Phase II study of antineoplaston A10 and AS2-1 in children with recurrent and progressive multicentric glioma : a preliminary report. Drugs R D 2004;5(6):315-326. PubMed
    5. 25620. Burzynski SR, Kubove E. Toxicology studies on antineoplaston A10 injections in cancer patients. Drugs Exp Clin Res 1986;12 Suppl 1:47-55.
    6. 20101. Burzynski SR, Mohabbat MO, Burzynski B. Human toxicology studies on oral formulation of Antineoplaston A10. Drugs Exp Clin Res 1984;10(12):891-909.

    “Orally and intravenously, antineoplastons AS2-1 and A10 have been associated with peripheral edema. Swelling of joints, muscle and joint pain, muscle contractions in the throat, weakness, and fatigue have been reported for patients treated with antineoplastons A2, AS2-1, AS2-5, and/or A10.”

    Antineoplastons · Natural Medicines adverse-effect record, reported in fatigue.

    5 sources cited
    1. 25604. Tsuda H, Hara H, Eriguchi N, et al. Toxicological study on antineoplastons A-10 and AS2-1 in cancer patients. Kurume Med J 1995;42(4):241-249. PubMed
    2. 25624. Burzynski SR. Toxicology studies on antineoplaston AS2-5 injections in cancer patients. Drugs Exp Clin Res 1986;12 Suppl 1:17-24.
    3. 25603. Burzynski SR, Lewy RI, Weaver RA, et al. Phase II study of antineoplaston A10 and AS2-1 in patients with recurrent diffuse intrinsic brain stem glioma: a preliminary report. Drugs R D 2003;4(2):91-101. PubMed
    4. 25620. Burzynski SR, Kubove E. Toxicology studies on antineoplaston A10 injections in cancer patients. Drugs Exp Clin Res 1986;12 Suppl 1:47-55.
    5. 25621. Burzynski SR, Kubove E. Initial clinical study with antineoplaston A2 injections in cancer patients with five years' follow-up. Drugs Exp Clin Res 1987;13 Suppl 1:1-11.

    Relugolix

    Listed in the ADVERSE REACTIONS section of the FDA label for Relugolix, and in voluntary FDA adverse-event reports. Read the label on DailyMed ›

  • Joint pain reported in 6.3% of FDA reports for Relugolix Additional detail

    Antineoplastons

    Recorded for Antineoplastons in the same Natural Medicines adverse-effect record shown under Tiredness above.

    Relugolix

    Listed in the ADVERSE REACTIONS section of the FDA label for Relugolix, and in voluntary FDA adverse-event reports. Read the label on DailyMed ›

  • Stomach pain Additional detail

    Antineoplastons

    “Orally, nausea, vomiting, upset stomach, abdominal pain, and excessive flatulence has been reported for patients with neoplastic disease treated with antineoplaston A10 100-149 mg/kg/day for up to 149 days.”

    Antineoplastons · Natural Medicines adverse-effect record, reported in flatulence.

    2 sources cited
    1. 20101. Burzynski SR, Mohabbat MO, Burzynski B. Human toxicology studies on oral formulation of Antineoplaston A10. Drugs Exp Clin Res 1984;10(12):891-909.
    2. 25620. Burzynski SR, Kubove E. Toxicology studies on antineoplaston A10 injections in cancer patients. Drugs Exp Clin Res 1986;12 Suppl 1:47-55.

    Relugolix

    Listed in the ADVERSE REACTIONS section of the FDA label for Relugolix. Read the label on DailyMed ›

Reported for Antineoplastons but not commonly for Relugolix: ringing in the ears, stomach upset, a fast or pounding heartbeat and raised blood pressure.

Effects for Relugolix come from the ADVERSE REACTIONS section of its FDA label; effects for Antineoplastons come from the Natural Medicines adverse-effect record, quoted above. Where a percentage is shown, it is the share of 24,018 voluntary FDA FAERS reports for Relugolix that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. Wording is matched across sources by our own clinical vocabulary, so treat this as a prompt to pay attention, not a diagnosis.

Overlapping uses

What Relugolix Is Prescribed For, and What Antineoplastons Has Been Studied For

These two come up together because they touch the same health topic — not because they do the same job. Relugolix is a prescription medicine with approved uses on its FDA label. Antineoplastons is a supplement: what follows is what researchers have looked at it for, and how strong that evidence is.

Relugolix is prescribed for: Orgovyx (relugolix) tablets are used to treat advanced prostate cancer in adults. It works by sharply lowering testosterone levels, which helps slow the growth of prostate cancer cells that depend on testosterone to grow.

Antineoplastons has been studied for:

  • Prostate cancer studied, not established Antineoplastons has been studied for this. Natural Medicines rates the evidence: Insufficient Reliable Evidence To Rate Read what the research shows

    Antineoplastons for prostate cancer

    Preliminary clinical research shows that administering AS2-1 along with diethylstilbestrol 0.01-0.02 mg/kg daily to patients with prostate cancer results in complete remission in 14% of patients, partial remission in 22% of patients, disease stabilization in 50% of patients, and disease progression in 14% of patients. This research suffers from poor study design and the lack of a comparator group.

    1 source cited
    1. 20102. Burzynski SR, Kubove E, Burzynski B. Treatment of hormonally refractory cancer of the prostate with antineoplaston AS2-1. Drugs Exp Clin Res 1990;16(7):361-369.

Effectiveness ratings and the research summaries above are the verbatim record from the Natural Medicines database, which grades evidence from “Effective” down to “Insufficient Reliable Evidence To Rate”. A rating below the top of that scale means researchers have looked at it — not that it works, and never that it can stand in for a prescribed medicine. Do not stop or replace Relugolix on your own; if you are taking Antineoplastons for the same health topic, tell your prescriber, especially if the medicine is being adjusted to a target.

From our Q&A

Questions About Antineoplastons or Relugolix

These are real questions from readers, answered by the pharmacists at HelloPharmacist — written by a person, not generated from a database. Each one covers Antineoplastons or Relugolix, not necessarily both, but if one is close to what you were about to ask it will usually go further than a database entry can:

Not quite your question? Ask our pharmacists directly — it is free, there is no account required, and answers usually come back within 24 hours.

Everything else you take

See Every Supplement That Interacts With Relugolix

This page covers Antineoplastons only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Relugolix page lists 152 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Activated Charcoal (major), American Hellebore (major), Arsenic (major), Cesium (major) and Ephedra (major).

By severity: 8 major · 107 moderate · 37 minor.

From our pharmacist’s overview on the Relugolix page

“Relugolix (Orgovyx) shuts down testosterone to treat prostate cancer, and I would handle its supplement list with genuine care, since 8 of the 152 entries carry a major rating. The bulk of the list, 121 ingredients, can change how much relugolix stays in your blood by acting on the CYP3A4 enzyme that clears it.”

Reviewed by 2 · Jul 18, 2026

Open the Relugolix interaction page

How much people look this up

Where Antineoplastons and Relugolix Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Antineoplastons
Steady interest

#1,084 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Relugolix
Steady interest

#1,683 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Antineoplastons reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 20, 2026. The Antineoplastons and Relugolix records this page draws on were last updated July 10, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Antineoplastons

What is Antineoplastons?

  • Cancer (various types, including brain tumors)
  • Adjunct cancer support
  • Investigational anticancer therapy

Antineoplastons are synthetic peptide and amino acid compounds promoted as an alternative cancer treatment, but they are not approved by the FDA and high-quality clinical evidence supporting their effectiveness is lacking. Most studies have been conducted by their developer and have not been independently confirmed. If you are considering them, talk with your oncologist first, and never replace proven cancer treatment with an unproven one.

Synthetic peptides, amino acid derivatives, and organic acids (originally isolated from human blood and urine) · Oral capsules and intravenous (IV) infusions, used mainly within specific clinics or research settings

An interaction check asks whether these two react with each other — it does not ask whether Antineoplastons is a good idea for someone in your situation. Here is what our Antineoplastons record says about it on its own.

Antineoplastons: dosing

There is no established, standardized safe dose of antineoplastons for any condition, and they are not available as a regular over-the-counter supplement. The doses studied have varied widely and were given under medical supervision, often as intravenous infusions.Because these products are unproven and can cause serious side effects, you should not try to dose them on your own. If you are considering antineoplastons, discuss it thoroughly with your oncologist and pharmacist first.

From our Antineoplastons monograph — the full record covers uses, side effects and every documented interaction.

Read the full Antineoplastons monograph & all interactions
Medication

About Relugolix

What Is Relugolix Used For?

Brand name: Orgovyx

Orgovyx (relugolix) tablets are used to treat advanced prostate cancer in adults. It works by sharply lowering testosterone levels, which helps slow the growth of prostate cancer cells that depend on testosterone to grow.

Most-Reported Side Effects for Relugolix

From FAERS, the FDA’s public side-effect reporting system (24,939 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Hot flush 7,500 reports
Fatigue 5,784 reports
Therapy interrupted 3,831 reports
Asthenia 1,930 reports
Arthralgia 1,564 reports
See full Relugolix drug information
Keep checking

Other Drugs & Antineoplastons

Browse every other medication we’ve checked against Antineoplastons — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
0Moderate
0Minor
2,829No known interaction
2,829 No interaction
No interaction 2,829 drugs checked — show the list

We also checked Antineoplastons against these medications and found no known interaction in our sources. Open any page to confirm.

Showing the 60 most looked-up of 2,829 medications checked with no known interaction — see the full Antineoplastons list.

See the full Antineoplastons interactions page
See every supplement checked against Relugolix, ranked by severity
Evidence & sources

Antineoplastons References

The 20 references that drive our Antineoplastons monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Burzynski SR, Stolzmann Z, Szopa B, Stolzmann E, Kaltenberg OP. Antineoplaston A in cancer therapy. (I). Physiol Chem Phys 1977;9(6):485-500.
  2. Burzynski SR, Mohabbat MO, Burzynski B. Human toxicology studies on oral formulation of Antineoplaston A10. Drugs Exp Clin Res 1984;10(12):891-909.
  3. Burzynski SR, Kubove E, Burzynski B. Treatment of hormonally refractory cancer of the prostate with antineoplaston AS2-1. Drugs Exp Clin Res 1990;16(7):361-369.
  4. Buckner JC, Malkin MG, Reed E, et al. Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma. Mayo Clin Proc 1999;74(2):137-145. PubMed
  5. Burzynski SR, Conde AB, Peters A, et al. A retrospective study of antineoplastons A10 and AS2-1 in primary brain tumors. Clin Drug Invest 1999;18(1):1-10.
  6. Burzynski SR, Lewy RI, Weaver RA, et al. Phase II study of antineoplaston A10 and AS2-1 in patients with recurrent diffuse intrinsic brain stem glioma: a preliminary report. Drugs R D 2003;4(2):91-101. PubMed
  7. Tsuda H, Hara H, Eriguchi N, et al. Toxicological study on antineoplastons A-10 and AS2-1 in cancer patients. Kurume Med J 1995;42(4):241-249. PubMed
  8. Burzynski SR, Kubove E. Phase I clinical studies of antineoplaston A3 injections. Drugs Exp Clin Res 1987;13 Suppl 1:17-29.
  9. Burzynski SR, Kubove E, Burzynski B. Phase I clinical studies of antineoplaston A5 injections. Drugs Exp Clin Res 1987;13 Suppl 1:37-43.
  10. Burzynski SR, Weaver RA, Lewy RI, et al. Phase II study of antineoplaston A10 and AS2-1 in children with recurrent and progressive multicentric glioma : a preliminary report. Drugs R D 2004;5(6):315-326. PubMed
  11. Burzynski SR, Weaver RA, Janicki T, et al. Long-term survival of high-risk pediatric patients with primitive neuroectodermal tumors treated with antineoplastons A10 and AS2-1. Integr Cancer Ther 2005;4(2):168-177. PubMed
  12. Burzynski SR, Burzynski B, Mohabbat MO. Toxicology studies on antineoplaston AS2-1 injections in cancer patients. Drugs Exp Clin Res 1986;12 Suppl 1:25-35.
  13. Burzynski SR, Kubove E. Toxicology studies on antineoplaston A10 injections in cancer patients. Drugs Exp Clin Res 1986;12 Suppl 1:47-55.
  14. Burzynski SR, Kubove E. Initial clinical study with antineoplaston A2 injections in cancer patients with five years' follow-up. Drugs Exp Clin Res 1987;13 Suppl 1:1-11.
  15. Burzynski SR, Kubove E, Burzynski B. Phase I clinical studies of antineoplaston A5 injections. Drugs Exp Clin Res 1987;13 Suppl 1:37-43.

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Antineoplastons and Relugolix Together: Common Questions

Is it safe to take Antineoplastons with Relugolix?
We do not list a known interaction between Antineoplastons and Relugolix. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Do Antineoplastons and Relugolix have any of the same side effects?
Yes — our sources link each of them separately to 5 of the same effects. That is not an interaction: neither changes how your body handles the other. It does mean that if one of those effects turns up, it can be harder to tell which one is behind it. They are listed on this page with the source behind each.
Are Antineoplastons and Relugolix used for the same thing?
They overlap in purpose, which usually means the real question is whether you need both rather than whether they are safe together. This page lists the shared uses and how strong the evidence is for Antineoplastons in each. That is a conversation for your prescriber, especially if Relugolix is being adjusted to a target.
Does Relugolix interact with any supplements?
Yes. Relugolix has documented interactions with 152 supplements in our database — Antineoplastons is not one of them. The Relugolix interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Where next

Keep Exploring

Antineoplastons monograph Uses, safety profile, and every drug interaction in one place Relugolix drug information The full plain-English guide to this medication Relugolix supplement interactions Every supplement checked against Relugolix, ranked by severity Supplement interaction checker Check any supplement or product against your medications Browse medications A–Z Every drug we’ve checked against herbs & supplements References The 20 citations behind this page Ask a pharmacist Free, personal answer from our licensed team

Still Have a Question About Relugolix and Antineoplastons?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.